BGI Genomics Co., Ltd. (SHE:300676)
32.78
-1.61 (-4.68%)
Nov 20, 2026, 3:04 PM CST
BGI Genomics Revenue
BGI Genomics had revenue of 904.49M CNY in the quarter ending September 30, 2026, a decrease of -13.24%. This brings the company's total for the last twelve months to 3.72B, up 0.23% year-over-year. In the year 2025, BGI Genomics had annual revenue of 3.71B, down -4.18%. That makes BGI Genomics the 10,670th largest company in the world by revenue and 1,762nd in China.
Revenue (ttm)
3.72B
Revenue Growth
+0.23%
P/S Ratio
3.38
Revenue / Employee
1.04M
Employees
3,580
Market Cap
12.58B
Revenue by Geography
- Mainland China (Excluding Hong Kong, Macau and Taiwan) 3.13B 84.6%
- Asia (Including China, Hong Kong, Macau, and Taiwan) and Oceania 286.43M 7.7%
- Europe and Africa 224.64M 6.1%
- Americas 59.83M 1.6%
Fiscal year ended Dec 31, 2025 See the full BGI Genomics breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.71B | -161.54M | -4.18% |
| Dec 31, 2024 | 3.87B | -482.72M | -11.10% |
| Dec 31, 2023 | 4.35B | -2.70B | -38.33% |
| Jan 1, 2023 | 7.05B | 287.01M | 4.24% |
| Jan 1, 2022 | 6.77B | -1.63B | -19.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.